IRIS

RUSSO, ALESSANDRO

RUSSO, ALESSANDRO  

Dipartimento Scienze Biomediche  

Mostra records
Risultati 1 - 20 di 171 (tempo di esecuzione: 0.018 secondi).
Titolo Data di pubblicazione Autore(i) File
117P Family history of cancer and improved outcomes with first-line immunotherapy in NSCLC patients. 1-gen-2021 Cortellini, A; Buti, S; Di Maio, M; Giusti, R; Nigro, O; Cantini, L; Bria, E; Grossi, F; Torniai, M; De Tursi, M; Citarella, F; Mazzoni, F; Gelibter, A; Macerelli, M; Migliorino, Mr; Russo, A; Addeo, A; Porzio, G; Ficorella, C; Pinato, Dj.
1995PApplication of ESCAT and OncoKB scales in liquid biopsy (LB) in advanced NSCLC patients (pts): Is it feasible and reliable? 1-gen-2019 Mccusker, M G; Russo, A; Chen, J; Scilla, K A; Mehra, R; Rolfo, C D
31 Dynamic change of PD-L1 expression on extracellular vesicles predicts response to immune-checkpoint inhibitors in non-small cell lung cancer patients 1-gen-2020 De Miguel Perez, D; Russo, A; Gunasekaran, M; Cardona, A; Lapidus, R; Cooper, B; Et, Al.
55P - Incidence and clinical implications of late immune-related adverse events in long responders to PD-1/PD-L1 checkpoint inhibitors: a multicenter study. 1-gen-2019 Nigro, O; Cortellini, A; Giusti, R; Marchetti, P; De Galitiis, F; Di Pietro, F; Bersanelli, M; Lazzarin, A; Galetta, D; Pizzutillo, P; Santini, D; Torniai, M; De Giglio, A; Russo, A; Silva, R; Bolzacchini, E; Natoli, C; Rijavec, E; Silva, R; Vallini, I; Pinotti, G.
A decade of EGFR inhibition in EGFR-mutated non small cell lung cancer (NSCLC): old successes and future perspectives 1-gen-2015 Russo, Alessandro; Franchina, Tindara; Ricciardi, Giuseppina Rosaria; Picone, Antonio; Ferraro, Giuseppa; Zanghì, Mariangela; Toscano, Giuseppe; Giordano, Antonio; Adamo, Vincenzo
A High-Performing Plasma Metabolite Panel for Early-Stage Lung Cancer Detection 1-gen-2020 Zhang, L; Zheng, J; Ahmed, R; Huang, G; Reid, J; Mandal, R; Maksymuik, A; Sitar, Ds; Tappia, Ps; Ramjiawan, B; Joubert, P; Russo, A; Rolfo, Cd; Wishart, Ds.
A New Generation of Vaccines in the Age of Immunotherapy. 1-gen-2021 Addeo, A; Friedlaender, A; Giovannetti, E; Russo, A; de Miguel-Perez, D; Arrieta, O; Cardona, Af; Rolfo, C.
A novel approach for the non-invasive diagnosis of pulmonary nodules using low-depth whole-genome sequencing of cell-free DNA 1-gen-2022 Zhang, B; Liang, H; Liu, W; Zhou, X; Qiao, S; Li, F; Tian, P; Li, C; Ma, Y; Zhang, H; Zhang, Z; Nanjo, S; Russo, A; Puig-Butillé, Ja; Wu, K; Wang, C; Zhao, X; Yue, D.
A Potentially New Targetable Alteration for the Treatment of Lung Cancer 1-gen-2021 Rosas, D; Raez, Le; Russo, A; Rolfo, C. Neuregulin 1 Gene (NRG1).
Acquired resistance in oncogene-addicted non-small-cell lung cancer 1-gen-2018 Sini, C.; Tuzi, A.; Rossi, G.; Russo, A.; Pezzuto, A.
Activity of EGFR tyrosine kinase inhibitors (TKIs) in brain metastases from Non Small Cell Lung Cancer (NSCLC) according to the EGFR mutational status: a survival analysis. 1-gen-2014 Picone, A; Franchina, T; Russo, A; Chiofalo, G; Scimone, A; Zanghì, M; Raiti, F; Agostino, Rm; Sava, S; Schifano, S; Silvestro, A; Smiroldo, V; Adamo, V.
ADCs and TCE in SCLC Therapy: The Beginning of a New Era? 1-gen-2025 Muscolino, Paola; Omero, Fausto; Speranza, Desirèe; Infurna, Carla; Parisi, Silvana; Cianci, Vincenzo; Berretta, Massimiliano; Russo, Alessandro; Santarpia, Mariacarmela
Adjuvant therapy in non-small cell lung cancer: is targeted therapy joining the standard of care? 1-gen-2021 Gabay, C; Russo, A; Raez, Le; Rolfo, C.
Advanced-stage ALK-positive non–small-cell lung cancer (NSCLC) patients: Real-world treatment patterns and outcomes from the Italian biomarker ATLAS database 1-gen-2025 Reale, Maria Lucia; Scattolin, Daniela; Vitale, Antonio; Passiglia, Francesco; Grisanti, Salvatore; Macerelli, Marianna; Galetta, Domenico; Sini, Claudio; Minuti, Gabriele; Citarella, Fabrizio; Roca, Elisa; Agustoni, Francesco; Dodi, Alessandra; Cortinovis, Diego; Belluomini, Lorenzo; Ricciardi, Serena; Veccia, Antonello; Pizzutilo, Elio Gregory; Scotti, Vieri; Alì, Greta; Mazzoni, Francesca; Russo, Alessandro; Pignataro, Daniele; Bulotta, Alessandra; Piovano, Pierluigi; Sergi, Concetta; Bettini, Anna; Genova, Carlo; Pavan, Alberto; Soto Parra, Hector José; Ortega, Cinzia; Pozzessere, Daniele; Vavalà, Tiziana; Chiari, Rita; Zannori, Cristina; D'Aveni, Alessandro; Meoni, Giulia; Giannarelli, Diana; Malapelle, Umberto; Novello, Silvia; Bria, Emilio; Pasello, Giulia
Application of ESCAT and OncoKB scales in liquid biopsy (LB) in advanced NSCLC patients (pts): Is it feasible and reliable? 1-gen-2019 Mccusker, Mg; Russo, A; Chen, J; Scilla, Ka; Mehra, R; Rolfo, Cd.
Association between baseline absolute neutrophil count (ANC), derived neutrophil-to-lymphocyte ratio (dNLR), and platelet-to-lymphocyte ratio (PLR) and response to nivolumab (Nivo) in non-small cell lung cancer (NSCLC): A preliminary analysis. 1-gen-2017 Russo, A; Scimone, A; Picciotto, M; Toscano, G; Raiti, F; Sava, S; Battaglia, A; Adamo, V.
Association of hepatitis B virus infection status with outcomes of non-small cell lung cancer patients undergoing anti-PD-1/PD-L1 therapy. 1-gen-2021 Zhang, X; Tian, D; Chen, Y; Chen, C; He, Ln; Zhou, Y; Li, H; Lin, Z; Chen, T; Wang, Y; Russo, A; Nadal, E; Passiglia, F; Soo, Ra; Watanabe, S; Moran, T; Oh, Ij; Fu, S; Hong, S; Zhang, L.
Atypical skin manifestations during immune checkpoint blockage in COVID19-infected lung cancer patients. 1-gen-2020 Rolfo, C; Cardona, Af; Ruiz-Patiño, A; Ariza, S; Zatarain-Barron, L; Pino, Le; Viola, L; Russo, A; Rojas, L; Ricaurte, L; Arrieta, O
B7-H3/CD276 Inhibitors: Is There Room for the Treatment of Metastatic Non-Small Cell Lung Cancer? 1-gen-2022 Malapelle, U; Parente, P; Pepe, F; Di Micco, Mc; Russo, A; Clemente, C; Graziano, P; Rossi, A.
Baseline Absolute Neutrophil Count (ANC), derived Neutrophil-to-Lymphocyte Ratio (dNLR) and Platelet-to-Lymphocyte Ratio (PLR) and outcome in Non Small Cell Lung Cancer (NSCLC) treated with Nivolumab or Docetaxel: a preliminary analysis. 1-gen-2017 Russo, A; Scimone, A; Picciotto, M; Toscano, G; Raiti, F; Sava, S; Battaglia, A; Adamo, V.